⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001843665

Garabedian Christopher Nishan

Reports to the SEC for 1 company · BLACKSBURG, VA

Transactions

6

Companies

1

Filings

4

CIK

0001843665

Forms 4 and 5

Insider transactions

6 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-05-23	Landos Biopharma, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,800 sh	—	—	0
2024-05-23	Landos Biopharma, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,800 sh	—	—	0
2024-05-23	Landos Biopharma, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,800 sh	—	—	0
2023-05-23	Landos Biopharma, Inc.Stock Option (right to buy)A Award	Director	AAward	+18K sh	—	—	18,000
2022-06-07	Landos Biopharma, Inc.Stock Option (right to buy)A Award	Director	AAward	+18K sh	—	—	18,000
2022-05-16	Landos Biopharma, Inc.Stock Option (right to buy)A Award	Director	AAward	+18K sh	—	—	18,000

Recent filings

4

Accepted (ET)
May 234
Garabedian Christopher Nishan0001415889-24-014336
SEC(opens sec.gov)
May 244
Garabedian Christopher Nishan0001209191-23-031943
SEC(opens sec.gov)
Jun 94
Garabedian Christopher Nishan0001209191-22-035285
SEC(opens sec.gov)
May 184
Garabedian Christopher Nishan0001209191-22-030044
SEC(opens sec.gov)

Companies

1

Landos Biopharma, Inc.Director

Address

C/O LANDOS BIOPHARMA, INC. 1800 KRAFT DRIVE, SUITE 216

BLACKSBURG, VA, 24060